Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Recruiting
Observational Study
Rheumatoid Arthritis (RA
Osteoporosis
Osteoarthritis
Interstitial Lung Disease
Thyroid Diseases
Cardiovascular Diseases
Pulmonary Complications
Sjogren's Syndrome
Liver Disorders
Renal Lesions
Vasculitis
Amyloidosis
Peripheral Neuropathy
Thrombosis
RA Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Generative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the diagnosis of various complications of rheumatoid arthritis (RA). In a retrospective study using RA patients' EHR records, we will quantify physician adoption of GenAI predictions for RA complications and co-existing diseases…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with an initial diagnosis of rheumatoid arthritis (RA).
* All real-world RA inpatients admitted to our department.
* Admission occurring within the real-world data study period.
Exclusion Criteria:
* Patients subsequently confirmed not to have RA during the study.
Contacts
Quan Jiang Guang'anmen Hospital, China Academy of Chinese Medical Science
010-88001942
CONTACT